The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

2017

Trubiano, Jason

Stone, Cosby A

Grayson, M Lindsay

Urbancic, Karen F

Slavin, Monica A

Thursky, Karin A

Phillips, Elizabeth J

Antibiotic allergy

Antimicrobial allergy

Cephalosporin allergy

Cross-reactivity

Penicillin allergy

Prevalence

Journal Article

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

10.1016/j.jaip.2017.06.017

Antibiotic allergy labeling is highly prevalent and negatively impacts patient outcomes and antibiotic appropriateness. Reducing the prevalence and burden of antibiotic allergies requires the engagement of key stakeholders such as allergists, immunologists, pharmacists, and infectious diseases physicians. To help address this burden of antibiotic allergy overlabeling, we review 3 key antibiotic allergy domains: (1) antibiotic allergy classification, (2) antibiotic cross-reactivity, and (3) multidisciplinary collaboration. We review the available evidence and research gaps of currently used adverse drug reaction classification systems, antibiotic allergy cross-reactivity, and current and future models of antibiotic allergy care.

link

The Journal of Allergy and Clinical Immunology. In Practice 2017; 5(6): 1532-1542

The Journal of Allergy and Clinical Immunology. In Practice